Grant: Discovery Grants Program - Individual
The University of British Columbia
$48,000.00
Developing New Tools for Bioanalysis and Imaging Using Advanced Fluorescent Materials
FY 2023-24
Summary
Canadian and global health care faces many challenges in the years ahead. Advances in science and technology will be critical to finding solutions to these challenges. The proposed research program aims to develop fluorescent materials, methods and technologies for the analysis of biological markers that are relevant to health and disease. Nanoparticle materials called “quantum dots” and “polymer dots” will be used to develop new point-of-care diagnostic methods and new fluorescent probes for biomedical research. Point-of-care diagnostics are low-cost and rapid medical tests done at the doctor's office or hospital bedside rather than in a specialized laboratory with sophisticated equipment operated by highly-trained people. In this context, our goals include the development of quantum dot- and polymer dot-enabeled, smartphone-based platforms for (i) measuring low-abundance biomarkers, (ii) the detection of multiple cell types via novel optical barcodes, and (iii) fingerprinting complex enzyme activity relevant to diseases such as cancer. In the context of fluorescent probes, we will use quantum dot-based “concentric FRET” (cFRET) probes with unique capabilities to study and gain new insight into cellular processes. These probes represent novel tools that will help advance biomedical research toward improved diagnosis and treatment of disease. Our goals include (i) real-time, quantitative observation of enzymatic cascades associated with cell death, the misregulation of which is implicated in diseases such as cancers and neurodegeneration; (ii) measuring biomarkers excreted from growing tumour cells to gain insight into their biology and treatment; and (iii) pushing cFRET probes to detect biomarkers at the level of single molecules. This balanced mix of fundamental and applied research will help train the next generation of scientists, has potential for future commercialization, and, through prospective contributions to the future of health care, will help Canadians attain better quality-of-life..
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2018-04276
Name nom
Algar, W Russ
Department département
Chemistry - Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2018
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Bioanalytical chemistry
Research subject en
Chimie analytique
Research subject fr
Chimie bioanalytique
Application title
Developing New Tools for Bioanalysis and Imaging Using Advanced Fluorescent Materials
Keyword
Extracellular sensing; Fluorescence; Imaging; Intracellular sensing; Nanoparticles; Point-of-care diagnostics; Polymer dots; Quantum dots; Resonance Energy transfer; Spectroscopy
Application summary
Canadian and global health care faces many challenges in the years ahead. Advances in science and technology will be critical to finding solutions to these challenges. The proposed research program aims to develop fluorescent materials, methods and technologies for the analysis of biological markers that are relevant to health and disease. Nanoparticle materials called “quantum dots” and “polymer dots” will be used to develop new point-of-care diagnostic methods and new fluorescent probes for biomedical research. Point-of-care diagnostics are low-cost and rapid medical tests done at the doctor's office or hospital bedside rather than in a specialized laboratory with sophisticated equipment operated by highly-trained people. In this context, our goals include the development of quantum dot- and polymer dot-enabeled, smartphone-based platforms for (i) measuring low-abundance biomarkers, (ii) the detection of multiple cell types via novel optical barcodes, and (iii) fingerprinting complex enzyme activity relevant to diseases such as cancer. In the context of fluorescent probes, we will use quantum dot-based “concentric FRET” (cFRET) probes with unique capabilities to study and gain new insight into cellular processes. These probes represent novel tools that will help advance biomedical research toward improved diagnosis and treatment of disease. Our goals include (i) real-time, quantitative observation of enzymatic cascades associated with cell death, the misregulation of which is implicated in diseases such as cancers and neurodegeneration; (ii) measuring biomarkers excreted from growing tumour cells to gain insight into their biology and treatment; and (iii) pushing cFRET probes to detect biomarkers at the level of single molecules. This balanced mix of fundamental and applied research will help train the next generation of scientists, has potential for future commercialization, and, through prospective contributions to the future of health care, will help Canadians attain better quality-of-life..